Target intelligence / Profile preview

Sialic acid binding immunoglobulin-like lectin 30, pseudogene (SIGLEC30P)

Target: SIGLEC30P
Molecular classification: Other, Pseudogene

Overview

Sialic acid binding immunoglobulin-like lectin 30, pseudogene (SIGLEC30P) is a human pseudogene belonging to the SIGLEC (sialic acid binding immunoglobulin-like lectin) gene family. As a pseudogene, SIGLEC30P is a non-functional genomic segment similar to functional SIGLEC genes; it does not produce a functional protein product, nor does it act as a conventional therapeutic target, receptor, or enzyme. SIGLEC genes typically encode receptors involved in cell–cell recognition and immune signaling, but pseudogenes like SIGLEC30P lack protein-coding capacity and classical biological function[1][4][8].

Other names: SIGLECP14

Beyond the preview

Go deeper on Sialic acid binding immunoglobulin-like lectin 30, pseudogene (SIGLEC30P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid binding immunoglobulin-like lectin 30, pseudogene (SIGLEC30P).

Explore the full profile